{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T20:31:28Z","timestamp":1776457888563,"version":"3.51.2"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:00:00Z","timestamp":1626652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["K01HL141538"],"award-info":[{"award-number":["K01HL141538"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Medications frequently require prior authorization from payers before filling is authorized. Obtaining prior authorization can create delays in filling prescriptions and ultimately reduce patient adherence to medication. Electronic prior authorization (ePA), embedded in the electronic health record (EHR), could remove some barriers but has not been rigorously evaluated. We sought to evaluate the impact of implementing an ePA system on prescription filling.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Materials and Methods<\/jats:title>\n                  <jats:p>ePA was implemented in 2 phases in September and November 2018 in a large US healthcare system. This staggered implementation enabled the later-implementing sites to be controls. Using EHR data from all prescriptions written and linked information on whether prescriptions were filled at pharmacies, we 1:1 matched ePA prescriptions with non-ePA prescriptions for the same insurance plan, medication, and site, before and after ePA implementation, to evaluate primary adherence, or the proportion of prescriptions filled within 30 days, using generalized estimating equations. We also conducted concurrent analyses across sites during the peri-implementation period (Sept\u2013Oct 2018).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 74 546 eligible ePA prescriptions, 38 851 were matched with preimplementation controls. In total, 24 930 (64.2%) ePA prescriptions were filled compared with 26 731 (68.8%) control prescriptions (Adjusted Relative Risk [aRR]: 0.92, 95%CI: 0.91\u20130.93). Concurrent analyses revealed similar findings (64.7% for ePA vs 62.3% control prescriptions, aRR: 1.03, 95%CI: 0.98\u20131.09).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>Challenges with implementation, such as misfiring and insurance fragmentation, could have undermined its effectiveness, providing implications for other health informatics interventions deployed in outpatient care.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Despite increasing interest in implementing ePA to improve prescription filling, adoption did not change medication adherence.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jamia\/ocab119","type":"journal-article","created":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T20:07:59Z","timestamp":1622750879000},"page":"2233-2240","source":"Crossref","is-referenced-by-count":13,"title":["Impact of implementing electronic prior authorization on medication filling in an electronic health record system in a large healthcare system"],"prefix":"10.1093","volume":"28","author":[{"given":"Julie C","family":"Lauffenburger","sequence":"first","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts, USA"}]},{"given":"Cheryl D","family":"Stults","sequence":"additional","affiliation":[{"name":"Department of Research, Development & Dissemination, Sutter Health, Research, Development & Dissemination, Walnut Creek, California, USA"}]},{"given":"Satish","family":"Mudiganti","sequence":"additional","affiliation":[{"name":"Department of Research, Development & Dissemination, Sutter Health, Research, Development & Dissemination, Walnut Creek, California, USA"}]},{"given":"Xiaowei","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Research, Development & Dissemination, Sutter Health, Research, Development & Dissemination, Walnut Creek, California, USA"}]},{"given":"Lisa M","family":"Dean-Gilley","sequence":"additional","affiliation":[{"name":"Department of Research, Development & Dissemination, Sutter Health, Research, Development & Dissemination, Walnut Creek, California, USA"}]},{"given":"Mengdong","family":"He","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts, USA"}]},{"given":"Angela","family":"Tong","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts, USA"}]},{"given":"Michael A","family":"Fischer","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts, USA"}]}],"member":"286","published-online":{"date-parts":[[2021,7,19]]},"reference":[{"issue":"10","key":"2021091817521939700_ocab119-B1","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/jama.2018.1150","article-title":"Health care spending in the United States and other high-income countries","volume":"319","author":"Papanicolas","year":"2018","journal-title":"Jama"},{"issue":"8","key":"2021091817521939700_ocab119-B2","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1377\/hlthaff.2010.0893","article-title":"US physician practices versus Canadians: spending nearly four times as much money interacting with payers","volume":"30","author":"Morra","year":"2011","journal-title":"Health Aff"},{"issue":"1","key":"2021091817521939700_ocab119-B3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1472-6963-14-109","article-title":"Practice characteristics and prior authorization costs: secondary analysis of data collected by SALT-Net in 9 central New York primary care practices","volume":"14","author":"Epling","year":"2014","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"2021091817521939700_ocab119-B4","doi-asserted-by":"crossref","first-page":"374","DOI":"10.18553\/jmcp.2013.19.5.374","article-title":"Retrospective database analysis of the impact of prior authorization for type 2 diabetes medications on health care costs in a Medicare Advantage Prescription Drug Plan population","volume":"19","author":"Bergeson","year":"2013","journal-title":"J Manag Care Pharm"},{"issue":"2","key":"2021091817521939700_ocab119-B5","first-page":"e52\u201360","article-title":"Formulary restrictions on atypical antipsychotics: impact on costs for patients with schizophrenia and bipolar disorder in Medicaid","volume":"20","author":"Seabury","year":"2014","journal-title":"Am J Manag Care"},{"issue":"8","key":"2021091817521939700_ocab119-B6","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/jama.2020.0070","article-title":"Changing the game of prior authorization: the patient perspective","volume":"323","author":"Gaines","year":"2020","journal-title":"Jama"},{"issue":"2","key":"2021091817521939700_ocab119-B7","first-page":"123","article-title":"The effects of antihypertensive step-therapy protocols on pharmaceutical and medical utilization and expenditures","volume":"15","author":"Mark","year":"2009","journal-title":"Am J Manag Care"},{"issue":"5","key":"2021091817521939700_ocab119-B8","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","article-title":"A new taxonomy for describing and defining adherence to medications","volume":"73","author":"Vrijens","year":"2012","journal-title":"Br J Clin Pharm"},{"issue":"10","key":"2021091817521939700_ocab119-B9","doi-asserted-by":"crossref","first-page":"633","DOI":"10.7326\/0003-4819-153-10-201011160-00005","article-title":"The epidemiology of prescriptions abandoned at the pharmacy","volume":"153","author":"Shrank","year":"2010","journal-title":"Ann Intern Med"},{"issue":"4","key":"2021091817521939700_ocab119-B10","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s11606-010-1253-9","article-title":"Primary medication nonadherence: analysis of 195,930 electronic prescriptions","volume":"25","author":"Fischer","year":"2010","journal-title":"J Gen Intern Med"},{"issue":"2","key":"2021091817521939700_ocab119-B11","first-page":"124","article-title":"A randomized telephone intervention trial to reduce primary medication nonadherence","volume":"21","author":"Fischer","year":"2015","journal-title":"J Manag Care Spec Pharm"},{"issue":"8","key":"2021091817521939700_ocab119-B12","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1001\/jama.2019.21428","article-title":"Refocusing medication prior authorization on its intended purpose","volume":"323","author":"Resneck","year":"2020","journal-title":"Jama"},{"issue":"8","key":"2021091817521939700_ocab119-B13","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/ajhp\/zxaa031","article-title":"Medications requiring prior authorization across health insurance plans","volume":"77","author":"Jones","year":"2020","journal-title":"Am J Health-Syst Pharm"},{"issue":"9","key":"2021091817521939700_ocab119-B14","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.sapharm.2018.09.019","article-title":"Medication prior authorization from the providers perspective: a prospective observational study","volume":"15","author":"Bhattacharjee","year":"2019","journal-title":"Res Soc Adm Pharm"},{"issue":"7","key":"2021091817521939700_ocab119-B15","doi-asserted-by":"crossref","first-page":"e006564","DOI":"10.1161\/CIRCOUTCOMES.120.006564","article-title":"Streamlining and reimagining prior authorization under value-based contracts: a call to action from the value in healthcare initiative's prior authorization learning collaborative","volume":"13","author":"Psotka","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"4","key":"2021091817521939700_ocab119-B16","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/j.japh.2020.01.012","article-title":"Implementation and impact assessment of integrated electronic prior authorization in an academic health system","volume":"60","author":"Birdsall","year":"2020","journal-title":"J Am Pharm Assoc"},{"issue":"4","key":"2021091817521939700_ocab119-B17","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MLR.0000000000000328","article-title":"Health care system-level factors associated with performance on Medicare STAR adherence metrics in a large, integrated delivery system","volume":"53","author":"Schmittdiel","year":"2015","journal-title":"Med Care"},{"issue":"2","key":"2021091817521939700_ocab119-B18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/M15-2659","article-title":"Association between patient-centered medical homes and adherence to chronic disease medications: a cohort study","volume":"166","author":"Lauffenburger","year":"2017","journal-title":"Ann Intern Med"},{"key":"2021091817521939700_ocab119-B19","year":"2019"},{"key":"2021091817521939700_ocab119-B20","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/MLR.0b013e31829b1d2a","article-title":"Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases","volume":"51 (8 Suppl 3","author":"Raebel","year":"2013","journal-title":"Med Care"},{"key":"2021091817521939700_ocab119-B21"},{"issue":"10","key":"2021091817521939700_ocab119-B22","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/aje\/kwg074","article-title":"Estimating the relative risk in cohort studies and clinical trials of common outcomes","volume":"157","author":"McNutt","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"7","key":"2021091817521939700_ocab119-B23","first-page":"677","article-title":"A systematic literature review assessing the directional impact of managed care formulary restrictions on medication adherence, clinical outcomes, economic outcomes, and health care resource utilization","volume":"20","author":"Happe","year":"2014","journal-title":"J Manag Care Spec Pharm"},{"issue":"1","key":"2021091817521939700_ocab119-B24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/MLR.0b013e3181bd4c10","article-title":"Unintended impacts of a Medicaid prior authorization policy on access to medications for bipolar illness","volume":"48","author":"Lu","year":"2010","journal-title":"Med Care"},{"issue":"6","key":"2021091817521939700_ocab119-B25","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.jaad.2019.05.024","article-title":"Examining the prior authorization process, patient outcomes, and the impact of a pharmacy intervention: a single-center review","volume":"81","author":"Popatia","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2021091817521939700_ocab119-B26"},{"key":"2021091817521939700_ocab119-B27","author":"Forster-Broten","year":"2019"},{"key":"2021091817521939700_ocab119-B28"},{"issue":"5","key":"2021091817521939700_ocab119-B29","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/jamia\/ocv192","article-title":"Effects of an e-Prescribing interface redesign on rates of generic drug prescribing: exploiting default options","volume":"23","author":"Malhotra","year":"2016","journal-title":"J Am Med Inform Assoc"},{"issue":"10_Supplement","key":"2021091817521939700_ocab119-B30","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.7326\/M13-3001","article-title":"Using default options within the electronic health record to increase the prescribing of generic-equivalent medications: a quasi-experimental study","volume":"161","author":"Patel","year":"2014","journal-title":"Ann Intern Med"},{"issue":"9","key":"2021091817521939700_ocab119-B31","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1037\/a0032925","article-title":"The effect of defaults in an electronic health record on laboratory test ordering practices for pediatric patients","volume":"32","author":"Probst","year":"2013","journal-title":"Health Psychol"},{"issue":"4","key":"2021091817521939700_ocab119-B32","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jcps.2011.06.003","article-title":"Enhanced active choice: a new method to motivated behavior change","volume":"21","author":"Keller","year":"2011","journal-title":"J Consumer Psychol"},{"issue":"1","key":"2021091817521939700_ocab119-B33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11606-016-3805-0","article-title":"How primary care physicians integrate price information into clinical decision-making","volume":"32","author":"Schiavoni","year":"2017","journal-title":"J Gen Intern Med"},{"key":"2021091817521939700_ocab119-B34","first-page":"2333392815572340","article-title":"Impact of information technology, clinical resource constraints, and patient-centered practice characteristics on quality of care","volume":"2","author":"Baek","year":"2015","journal-title":"Health Serv Res Manag Epidemiol"}],"container-title":["Journal of the American Medical Informatics Association"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jamia\/article-pdf\/28\/10\/2233\/40408806\/ocab119.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jamia\/article-pdf\/28\/10\/2233\/40408806\/ocab119.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T17:52:49Z","timestamp":1631987569000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jamia\/article\/28\/10\/2233\/6324039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,19]]},"references-count":34,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,7,19]]},"published-print":{"date-parts":[[2021,9,18]]}},"URL":"https:\/\/doi.org\/10.1093\/jamia\/ocab119","relation":{},"ISSN":["1527-974X"],"issn-type":[{"value":"1527-974X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2021,7,19]]}}}